Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.
about
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic ResistanceIncreased sporulation rate of epidemic Clostridium difficile Type 027/NAP1Therapy of Clostridium difficile infection: perspectives on a changing paradigm.Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
P2860
Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mutations in fusA associated w ...... ance in Clostridium difficile.
@en
Mutations in fusA associated w ...... ance in Clostridium difficile.
@nl
type
label
Mutations in fusA associated w ...... ance in Clostridium difficile.
@en
Mutations in fusA associated w ...... ance in Clostridium difficile.
@nl
prefLabel
Mutations in fusA associated w ...... ance in Clostridium difficile.
@en
Mutations in fusA associated w ...... ance in Clostridium difficile.
@nl
P2093
P2860
P356
P1476
Mutations in fusA associated w ...... ance in Clostridium difficile.
@en
P2093
P2860
P304
P356
10.1128/AAC.01283-06
P407
P577
2007-02-16T00:00:00Z